Skip to main content
SpringerLink
Log in
Menu
Find a journal Publish with us Track your research
Search
Cart
  1. Home
  2. Archives of Virology
  3. Article

The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens

  • Original Papers
  • Published: March 1994
  • Volume 138, pages 117–134, (1994)
  • Cite this article
Download PDF
Archives of Virology Aims and scope Submit manuscript
The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens
Download PDF
  • J. Ignjatovic1 &
  • L. Galli1 
  • 464 Accesses

  • 126 Citations

  • 3 Altmetric

  • Explore all metrics

Summary

The S1, N and M proteins, obtained from the nephropathogenic N1/62 strain of infectious bronchitis virus (IBV) by immunoaffinity purification with monoclonal antibodies, were used for immunization of chickens. For all three antigens multiple immunizations were necessary for induction of an antibody response. Protection of chickens vaccinated with the S1 glycoprotein against virulent challenge was demonstrated by the complete absence of virus in tracheas and kidneys of vaccinated chickens. Following four immunizations with the S1 glycoprotein 71% and 86% of chickens were protected at the level of tracheas and kidneys, respectively. Three immunizations with the S1 glycoprotein protected 70% and 10% of chickens at the level of kidney and trachea, respectively. Neither the N nor the M antigen induced protection to a virulent challenge with the nephropathogenic N1/62 strain of IBV after four immunizations. Virus neutralizing, haemagglutination inhibiting and ELISA antibodies were detected in chickens immunized with the S1 glycoprotein and inactivated N1/62 virus, however there was no correlation between the presence of any of these antibodies and protection.

Article PDF

Download to read the full article text

Similar content being viewed by others

Protection conferred by a vaccine derived from an inactivated Egyptian variant of infectious bronchitis virus: a challenge experiment

Article 24 April 2019

Emad Al-Ebshahy, Mohammed Abdel-Sabour, … Tokuma Yanai

Generation of a recombinant chickenized monoclonal antibody against the neuraminidase of H9N2 avian influenza virus

Article Open access 20 August 2020

Fei Wang, Yajuan Wang, … Aijian Qin

Microneutralization Test of Avian Infectious Bronchitis Virus Using Vero Cells

Chapter © 2022
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

References

  1. Barthold SW, Smith AL (1989) Virus strain specificity of challenge immunity to coronavirus. Arch Virol 104: 187–196

    Google Scholar 

  2. Boots AMH, Kusters JG, Van Noort JM, Zwaagstra KA, Rijke E, Van Der Zeijst BAM, Hensen EJ (1991) Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 74: 8–13

    Google Scholar 

  3. Boots AMH, Benaissa-Trouw BJ, Hesselink W, Rijke E, Schrier C, Hensen EJ (1992) Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein. Vaccine 10: 119–124

    Google Scholar 

  4. Boursnell MEG, Binns MM, Foulds IJ, Brown TDK (1985) Sequences of the nucleocapsid genes from two strains of avian infectious bronchitis virus. J Gen Virol 66: 573–580

    Google Scholar 

  5. Cavanagh D (1983) Coronavirus IBV glycopolypeptides: size of their polypeptide moieties and nature of their oligosaccharides. J Gen Virol 64: 1187–1191

    Google Scholar 

  6. Cavanagh D (1983) Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides. J Gen Virol 64: 1787–1791

    Google Scholar 

  7. Cavanagh D (1983) Coronavirus IBV: structural characterization of the spike protein. J Gen Virol 64: 2577–2583

    Google Scholar 

  8. Cavanagh D, Darbyshire JH, Davis P, Peters RW (1984) Induction of humoral neutralising and haemagglutination-inhibiting antibody by the spike protein of avian infectious bronchitis virus. Avian Pathol 13: 573–583

    Google Scholar 

  9. Cavanagh D, Davis PJ, Darbyshire JH, Peters RW (1986) Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J Gen Virol 67: 1435–1442

    Google Scholar 

  10. Cook JKA, Davison TF, Huggins MB, Mclaughlan P (1991) Effect of in ovo bursectomy on the course of an infectious bronchitis virus infection in line C White Leghorn chickens. Arch Virol 118: 225–234

    Google Scholar 

  11. Daniel C, Talbot PJ (1990) Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology 174: 87–94

    Google Scholar 

  12. Darbyshire JH, Rowell JG, Cook JKA Peters RW (1979) Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures. Arch Virol 61: 227–238

    Google Scholar 

  13. De Diego M, Laviada MD, Ehjuanes L, Escribano JM (1992) Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus. J Virol 66: 6502–6508

    Google Scholar 

  14. De Groot RJ, Van Leen RW, Dalderup MJM, Vennema H, Horzinek MC, Spann WJM (1989) Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology 171: 493–502

    Google Scholar 

  15. Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA (1989) Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168: 162–167

    Google Scholar 

  16. Hasony HJ, Macnaughton MR (1981) Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57 strain mice. Arch Virol 69: 33–41

    Google Scholar 

  17. Homberger FR, Barthold SW (1992) Passively aquired challenge immunity to enterotropic coronavirus in mice. Arch Virol 126: 35–43

    Google Scholar 

  18. Ignjatovic J, Mcwaters PG (1991) Monoclonal antibodies to three structural proteins of avian infectious bronchitis virus: characterization of epitopes and antigenic differentiation of Australian strains. J Gen Virol 72: 2915–2922

    Google Scholar 

  19. King DJ, Cavanagh D (1991) Infectious bronchitis. In: Calnek BW, Barnes HJ, Beard CW, Reid WM, Yoder HW Jr (eds) Diseases of poultry, 9th edn. Iowa State University Press, Ames, pp 471–484

    Google Scholar 

  20. Koch G, Hartog L, Kant A, Van Roozelaar DJ (1990) Antigenic domains on the peplomer protein of avian infectious bronchitis virus: correlation with biological functions. J Gen Virol 71: 1929–1935

    Google Scholar 

  21. Koolen MJM, Borst MAJ, Horzinek MC, Spaan WJM (1990) Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J Virol 64: 6270–6273

    Google Scholar 

  22. Kusters JG, Jager EJ, Niesters HGM, Van Der Zeijst BAM (1990) Sequence evidence of RNA recombination in field isolates of avian coronavirus infectious bronchitis virus. Vaccine 8: 605–608

    Google Scholar 

  23. Kusters JG, Jager EJ, Lenstra JA, Koch G, Posthumus WPA, Meloen RH, Van Der Zeijst BAM (1989) Analysis of an immunodominant region of infectious bronchitis virus. J Immunol 143: 2692–2698

    Google Scholar 

  24. Lenstra JA, Kusters JG, Koch G, Van Der Zeijst BAM (1989) Antigenicity of the peplomer protein of infectious bronchitis virus. Mol Immunol 26: 7–15

    Google Scholar 

  25. Mobley J, Evans G, Dailey MO, Perlman S (1992) Immune response to a murine coronavirus: identification of a homing receptor-negative CD4+ T cell subset that responds to viral glycoproteins. Virology 187: 443–452

    Google Scholar 

  26. Mockett APA (1985) Envelope proteins of avian infectious bronchitis virus: purification and biological properties. J Virol Methods 12: 271–278

    Google Scholar 

  27. Mockett APA, Cavanagh D, Brown TDK (1984) Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41. J Gen Virol 65: 2281–2286

    Google Scholar 

  28. Perlman S, Schelper R, Ries D (1987) Maternal antibody-modulated MHV-JHM infection in C57BL/6 and Balb/c mice. Adv Exp Med Biol 218: 297–305

    Google Scholar 

  29. Spaan WJM (1990) Progress towards a coronavirus recombinant DNA vaccine. In: Cavanagh D, Brown TDK (Eds) Coronaviruses and their diseases. Plenum Press, New York, pp 201–203

    Google Scholar 

  30. Sturman LS, Ricard CS, Holmes KV (1985) Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90 K cleavage fragments. J Virol 56: 904–911

    Google Scholar 

  31. Sussman MA, Shubin RA, Kyuwa S, Stohlman SA (1989) T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol 63: 3051–3056

    Google Scholar 

  32. Talbot PJ, Dionne G, Lacroix M (1988) Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk. J Virol 62: 3032–3036

    Google Scholar 

  33. Vennema H, De Groot RJ, Harbour DA, Dalderup M, Gruffydd-Jones T, Horzinek MC, Spaan WJM (1990) Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol 64: 1407–1409

    Google Scholar 

  34. Vennema H, De Groot RJ, Harbour DA, Horzinek MC, Spaan WJM (1991) Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens. Virology 181: 327–335

    Google Scholar 

  35. Wang L, Junker D, Collisson EW (1993) Evidence of natural recombination within the S1 gene of infectious bronchitis virus. Virology 192: 710–716

    Google Scholar 

  36. Wesseling JG, Godeke G-J, Schijns VECJ, Prevec L, Graham FL, Horzinek MC, Rottier PJM (1993) Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. J Gen Virol 74: 2061–2069

    Google Scholar 

  37. Yamaguchi K, Goti N, Kyuwa S, Hayami M, Toyoda Y (1991) Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol 32: 1–9

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Animal Health Research Laboratory, CSIRO Division of Animal Health, Parkville, Victoria, Australia

    J. Ignjatovic & L. Galli

Authors
  1. J. Ignjatovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Galli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ignjatovic, J., Galli, L. The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens. Archives of Virology 138, 117–134 (1994). https://doi.org/10.1007/BF01310043

Download citation

  • Received: 06 January 1994

  • Accepted: 31 March 1994

  • Issue Date: March 1994

  • DOI: https://doi.org/10.1007/BF01310043

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Monoclonal Antibody
  • Infectious Disease
  • Antibody Response
  • Bronchitis
  • Haemagglutination Inhibit
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Advertisement

Search

Navigation

  • Find a journal
  • Publish with us
  • Track your research

Discover content

  • Journals A-Z
  • Books A-Z

Publish with us

  • Publish your research
  • Open access publishing

Products and services

  • Our products
  • Librarians
  • Societies
  • Partners and advertisers

Our imprints

  • Springer
  • Nature Portfolio
  • BMC
  • Palgrave Macmillan
  • Apress
  • Your US state privacy rights
  • Accessibility statement
  • Terms and conditions
  • Privacy policy
  • Help and support

5.135.140.155

Not affiliated

Springer Nature

© 2024 Springer Nature